Evidence map›Paper›PMID 22761260›Full record

ArticleInvestigative ophthalmology & visual science2012

Effects of proinflammatory cytokines on the claudin-19 rich tight junctions of human retinal pigment epithelium.

Shaomin Peng, Geliang Gan, Veena S Rao, Ron A Adelman, Lawrence J Rizzolo

Open access · bronzeAbstract read
In one paragraph

Article in Investigative ophthalmology & visual science, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 30 papers.

0numbers the graph read from it
0cells of the map it votes in
30citing papers in PubMed
4.2field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

30 citing papers in PubMed, 50 citations in OpenAlex.

  1. Review
  2. Complement C3 Activation in the Human Retinal Pigment Epithelium.Investigative ophthalmology & visual science · 2025
    Article
  3. Article
  4. Mechanisms of macular edema.Frontiers in medicine · 2023
    Review
  5. Basolateral activation with TLR agonists induces polarized cytokine release and reduces barrier function in RPE in vitro.Graefe's archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie · 2021
    Article
  6. Article
  7. Review
  8. Genetics of kidney stone disease.Nature reviews. Urology · 2020
    Review
  9. Article
  10. Article
  11. Xuebijing injection treatment inhibits vasopermeability and reduces fluid requirements in a canine burn model.European journal of trauma and emergency surgery : official publication of the European Trauma Society · 2017
    Article
  12. Article
  13. Article
  14. Interleukin-13 and age-related macular degeneration.International journal of ophthalmology · 2017
    Article
  15. Article
  16. S100A4 gene silencing in oxygen-induced ischemic retinopathy inhibits retinal neovascularization via down-regulation of CREB expression.Graefe's archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie · 2016
    Article
  17. Article
  18. Article
  19. Article
  20. NLRP3 Inflammasome and Pathobiology in AMD.Journal of clinical medicine · 2015
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Shaomin PengDepartment of Surgery, Yale University School of Medicine, New Haven, Connecticut, USA.
Geliang Gan
Veena S Rao
Ron A Adelman
Lawrence J Rizzolo
Yale University · US

Funding

Yale Core Grant For Vision ResearchP30EY000785 · NEI · YALE UNIVERSITY · PI TIAN, NING · 1985 to 2010
$5.8M
NEI NIH HHS EY000785NEI NIH HHS P30 EY000785
6 · The paper itself

Abstract

purposeChronic, subclinical inflammation contributes to the pathogenesis of several ocular diseases, including age-related macular degeneration. Proinflammatory cytokines affect tight junctions in epithelia that lack claudin-19, but in the retinal pigment epithelium claudin-19 predominates. We examined the effects of cytokines on the tight junctions of human fetal RPE (hfRPE).

methodshfRPE was incubated with interleukin 1-beta (IL-1β), interferon-gamma (IFNγ), or tumor necrosis factor-alpha (TNFα), alone or in combination. Permeability and selectivity of the tight junctions were assessed using nonionic tracers and electrophysiology. Claudins, occludin, and ZO-1 were examined using PCR, immunoblotting, and confocal immunofluorescence microscopy.

resultsOnly TNFα consistently reduced transepithelial electrical resistance (TER) >80%. A serum-free medium revealed two effects of TNFα: (1) decreased TER was observed only when TNFα was added to the apical side of the monolayer, and (2) expression of TNFα receptors and inhibitors of apoptosis were induced from either side of the monolayer. In untreated cultures, tight junctions were slightly cation selective, and this was affected minimally by TNFα. The results were unexplained by effects on claudin-2, claudin-3, claudin-19, occludin, and ZO-1, but changes in the morphology of the junctions and actin cytoskeleton may have a role.

conclusionsClaudin-19-rich tight junctions have low permeability for ionic and nonionic solutes, and are slightly cation-selective. Claudin-19 is not a direct target of TNFα. TNFα may protect RPE from apoptosis, but makes the monolayer leaky when it is presented to the apical side of the monolayer. Unlike other epithelia, IFNγ failed to augment the effect of TNFα on tight junctions.

Indexed as

Cells, CulturedClaudinsHumansInterferon-gammaInterleukin-1betaMembrane ProteinsOccludinPermeabilityPhosphoproteinsRetinal Pigment EpitheliumTight JunctionsTumor Necrosis Factor-alphaZonula Occludens-1 ProteinClaudinsInterferon-gammaInterleukin-1betaMembrane ProteinsOccludinOCLN protein, humanPhosphoproteinsTJP1 protein, humanTumor Necrosis Factor-alphaZonula Occludens-1 Protein

Identifiers

PMID22761260
PMCPMC3410691
OpenAlexW2093452444

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.